Hi Cancer Coach- My name is Bryan. I’m a 37 year old male living in Toronto Canada. I had a
procedure done last week that examined my stomach. I was told I had acid
burning or inflammation on my esophagus. The doctor told me that there was
no indication that there were any further problems. He gave me a medication
that would prevent the acid reflux and told me I have to change my diet to
avoid triggers. He told me after that he wants to make sure I do not have something called “Barrett’s Esophagus”.
He said there was no indication I have it but because of the inflammation from the acid damage to my esophagus, he can’t be certain.He told me I need to heal my esophagus first and scheduled me back for
another examination in 6 months to check again to make sure I do not have this.
I was researching how to prevent and help myself from having this issue in the future and I came across your website. My question to you is what do you
recommend that I do or what do you suggest I do to help prevent this and if I
do end up with the Barrett’s Esophagus, how best to treat it and prevent it from turning
I’m sorry if my questions aren’t very good. I’m ignorant about the specifics
with this Barrett’s Esophagus and Esophageal cancer. I’m just worried now after
being that the doctor doesn’t know for certain if I do not have it.
Thanks for taking the time to read this.
I can under how you feel. While you do not have cancer, you have a form of “pre-cancer.” Your risk of developing esophageal cancer is up to you, really. I’ll tell you why.
Statistically, the risk of a person who has BE getting EC is about 1% according to studies. However you can increase or decrease your risks through nutrition, supplementation and other evidence-based, lifestyle therapies.A good example is a supplement called curcumin.
Let me know if you have any questions.
Thanks and good luck,
“Based on a review of these studies, it is evident that better bioavailability of formulated curcumin (CU) products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism”
A search of the Pubmed database for the word curcumin yields 601 studies spaning health topics from multiple myeloma and colorectal cancer, to chemotherapies that synergizes with CU, to Alzheimer’s Disease, arthritis and more. Based on years of reading studies and personal accounts, I think it is safe to say that CU supplementation is safe and relatively inexpensive.
I have read about myeloma patients taking daily doses of CU from 400 milligrams to 8 grams (1000 milligrams = 1 gram). By almost any measure, CU is a safe, inexpensive wonder drug.
The only challenge is that CU is famously difficult to absorb in the body. In other words, a person has to mix curcumin with some sort of fat (coconut oil, chocolate, etc.) or take a brand of curcumin capsule that is already formulated to be more “bioavailable” in order to derive the full benefit of CU.
The study linked and exerpted below reviews different formulations of CU. The study itself lists the three most bioavailable formulation/brand of CU and I’ve added an excerpt from a further review from Consumerlab.com that lists four additional bioavailable brands of CU.
I consult the independent evaluation service Consumerlab.com frequently. For one low annual payment, I can read about and evaluate all of the nutritional supplement that I take.
“CU is a bright yellow chemical produced by some plants. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.“
“Curcumin is a widely studied natural compound which has shown tremendous in vitro therapeutic potential. Despite that, the clinical efficacy of the native CU is weak due to its low bioavailability and high metabolism in the gastrointestinal tract. During the last decade, researchers have come up with different formulations with a focus on improving the bioavailability of curcumin. As a result, a significant number of bioavailable curcumin-based formulations were introduced with the varying range of enhanced bioavailability.
The purpose of this review is to collate the published clinical studies of CU products with improved bioavailability over conventional (unformulated) CU. Based on the literature search, 11 curcumin formulations with available human bioavailability and pharmacokinetics data were included in this review. Further, the data on clinical study design, analytical method, pharmacokinetic parameters and other relevant details of each formulation were extracted.
Based on a review of these studies, it is evident that better bioavailability of formulated curcumin products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism. The review hopes to provide a quick reference guide for anyone looking information on these bioavailable curcumin formulations.
Based on the published reports,
exhibited over 100-fold higher bioavailability relative to reference unformulated CU. Suggested mechanisms accounting for improved bioavailability of the formulations and details on the bioanalysis methods are also discussed.”
According to Consumerlab.com:
“Novasol has the highest bioavailability (185 x compared to unforumulated CU), followed by Curcuwin (136 x), Longvida (100 x), Meriva (48 x), BCM-95 (27 x), Curcumin C3 Complex + Bioperene (20 x), and then Theracumin (16 x).”